查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1792391

糖尿病视网膜病变市场报告（按类型、治疗类型、最终用户（医院和药房、眼科诊所、门诊手术中心等）和地区）2025 年至 2033 年

Diabetic Retinopathy Market Report by Type, Treatment Type, End-User (Hospitals and Pharmacies, Eye Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球糖尿病视网膜病变市场规模达85亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到132亿美元，2025-2033年期间的复合年增长率（CAGR）为5%。糖尿病盛行率的飙升、对有效治疗的需求不断增长，以及人们对糖尿病视网膜病变早期诊断和治疗的认识不断提高，是推动市场发展的一些关键因素。

糖尿病视网膜病变 (DR) 是糖尿病的常见併发症，会影响视网膜——眼睛感知光线并向大脑发送信号的部分。高血糖值会损害视网膜中的小血管，导致其渗漏或阻塞，进而引发糖尿病视网膜病变。如果不及时治疗，可能会导致视力丧失或失明。糖尿病视网膜病变主要分为两种：非增生性糖尿病视网膜病变及增生性糖尿病视网膜病变。其诊断需要全面的眼科检查，其中可能包括萤光血管摄影和光学相干断层扫描等检查。这些检查有助于确定 DR 的存在及其严重程度，以便及早介入和治疗。目前，DR 的治疗方案包括眼内注射类固醇、雷射治疗和玻璃体切除术。眼内注射类固醇有助于减轻眼部发炎和肿胀，而雷射治疗则可以封闭渗漏的血管，防止视网膜进一步受损。在更严重的情况下，可能需要进行玻璃体切除术以去除眼睛中的血液或疤痕组织。

糖尿病视网膜病变市场趋势：

全球糖尿病视网膜病变市场正经历显着成长，主要原因是糖尿病盛行率上升和老年人口成长。同时，主要参与者正在积极开发新的糖尿病视网膜病变治疗方案，推动了市场成长。此外，抗VEGF药物和缓释植入物等新药和新疗法的开发也显着促进了市场成长。此外，远距医疗和人工智慧(AI)在糖尿病视网膜病变诊断和治疗中的日益普及也推动了市场成长。由于人们对糖尿病视网膜病变及其潜在后果的认识不断提高，对有效治疗的需求不断增长，这也是另一个促进成长的因素。此外，人们对糖尿病视网膜病变早期诊断和治疗认识的不断提高，加上眼科技术的进步，也推动了市场的成长。其他因素，例如医疗支出的增加、政府为改善眼部保健服务而实施的各种倡议以及优惠的报销政策，也在推动市场成长。

本报告回答的关键问题：

  • 全球糖尿病视网膜病变市场迄今表现如何，未来几年将如何表现？
  • 全球糖尿病视网膜病变市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球糖尿病视网膜病变市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表最具吸引力的糖尿病视网膜病变市场？
  • 根据类型，市场区隔是怎样的？
  • 糖尿病视网膜病变市场哪种类型最具吸引力？
  • 根据治疗类型，市场是如何分類的？
  • 糖尿病视网膜病变市场中哪种治疗类型最具吸引力？
  • 根据最终用户，市场是如何分類的？
  • 糖尿病视网膜病变市场中最具吸引力的终端用户是谁？
  • 全球糖尿病视网膜病变市场的竞争结构是怎么样的？
  • 全球糖尿病视网膜病变市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球糖尿病视网膜病变市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 增生性糖尿病视网膜病变
  • 非增生性视网膜病变

第七章：市场区隔：依治疗类型

  • 抗VEGF药物
  • 类固醇植入物
  • 雷射手术
  • 玻璃体切除术

第八章：市场区隔：按最终用户

  • 医院和药房
  • 眼科诊所
  • 门诊手术中心（ASC）
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alimera Sciences
    • Allergan Plc
    • Ampio Pharmaceuticals
    • Bayer Healthcare
    • BCN Peptides
    • Genentech
    • Kowa Group
    • Novartis AG
    • Regeneron Pharmaceuticals Inc.
    • Sirnaomics Inc.
Product Code: SR112025A1932

The global diabetic retinopathy market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.2 Billion by 2033, exhibiting a growth rate (CAGR) of 5% during 2025-2033. The surging prevalence of diabetes, rising demand for effective treatments, and growing awareness regarding early diagnosis and treatment of diabetic retinopathy represent some of the key factors driving the market.

Diabetic retinopathy (DR) is a common complication of diabetes that affects the retina, the part of the eye that senses light and sends signals to the brain. It occurs when high blood sugar levels damage the small blood vessels in the retina, causing them to leak or become blocked. This can lead to vision loss or blindness if left untreated. There are two main types of diabetic retinopathy, namely non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Its diagnosis involves a comprehensive eye exam, which may include tests such as fluorescein angiography and optical coherence tomography. These tests can help to identify the presence and severity of DR, allowing for early intervention and treatment. Currently, there are several treatment options available for DR, including the use of intraocular steroid injections, laser treatment, and vitrectomy. Intraocular steroid injections can help to reduce inflammation and swelling in the eye, while laser treatment can be used to seal leaking blood vessels and prevent further damage to the retina. In more severe cases, a vitrectomy may be necessary to remove blood or scar tissue from the eye.

Diabetic Retinopathy Market Trends:

The global diabetic retinopathy market is witnessing significant growth, primarily driven by the rising prevalence of diabetes and the increasing geriatric population. In line with this, key players are actively working to develop new therapeutic solutions for diabetic retinopathy, which is bolstering market growth. Apart from this, the development of new drugs and therapies, such as anti-VEGF agents and sustained-release implants, has also significantly contributed to market growth. Additionally, the escalating adoption of telemedicine and artificial intelligence (AI) in the diagnosis and treatment of diabetic retinopathy is driving the market growth. The rising demand for effective treatments due to the growing awareness of diabetic retinopathy and its potential consequences is acting as another growth-inducing factor. Furthermore, the surging awareness regarding early diagnosis and treatment of diabetic retinopathy, coupled with advancements in ophthalmic technology, are fueling the market growth. Other factors, such as increasing healthcare expenditure, the implementation of various government initiatives to improve eye care services, and the availability of favorable reimbursement policies, are propelling the market growth.

Key Market Segmentation:

Type Insights:

  • Proliferative Diabetic Retinopathy
  • Non-proliferative Retinopathy

Treatment Type Insights:

  • Anti VEGF Drugs
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

End-User Insights:

  • Hospitals and Pharmacies
  • Eye Clinics
  • Ambulatory Surgical Centres (ASCs)
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. As per the report, North America dominates the market. Some of the factors accelerating the North America diabetic retinopathy market include the increasing prevalence of diabetes, growing awareness about diabetic retinopathy, and advancements in diagnostic and treatment technologies.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global diabetic retinopathy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alimera Sciences, Allergan PLC, Ampio Pharmaceuticals, Bayer Healthcare, BCN Peptides, Genentech, Kowa Group, Novartis AG, Regeneron Pharmaceuticals Inc., Sirnaomics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global diabetic retinopathy market performed so far, and how will it perform in the coming years ?
  • What are the drivers, restraints, and opportunities in the global diabetic retinopathy market ?
  • What is the impact of each driver, restraint, and opportunity on the global diabetic retinopathy market ?
  • What are the key regional markets ?
  • Which countries represent the most attractive diabetic retinopathy market ?
  • What is the breakup of the market based on the type ?
  • Which is the most attractive type in the diabetic retinopathy market ?
  • What is the breakup of the market based on the treatment type ?
  • Which is the most attractive treatment type in the diabetic retinopathy market ?
  • What is the breakup of the market based on the end-user ?
  • Which is the most attractive end-user in the diabetic retinopathy market ?
  • What is the competitive structure of the global diabetic retinopathy market ?
  • Who are the key players/companies in the global diabetic retinopathy market ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetic Retinopathy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proliferative Diabetic Retinopathy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proliferative Retinopathy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Anti VEGF Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Steroid Implants
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Laser Surgeries
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitrectomy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eye Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centres (ASCs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Alimera Sciences
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
    • 13.3.2 Allergan Plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Ampio Pharmaceuticals
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Bayer Healthcare
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 BCN Peptides
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Genentech
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 SWOT Analysis
    • 13.3.7 Kowa Group
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Regeneron Pharmaceuticals Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Sirnaomics Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Diabetic Retinopathy Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetic Retinopathy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Diabetic Retinopathy Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Diabetic Retinopathy Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Diabetic Retinopathy Market: Breakup by End-User (in %), 2024
  • Figure 6: Global: Diabetic Retinopathy Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Diabetic Retinopathy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Diabetic Retinopathy (Proliferative Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Diabetic Retinopathy (Non-proliferative Retinopathy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Diabetic Retinopathy (Anti VEGF Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Diabetic Retinopathy (Steroid Implants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Diabetic Retinopathy (Steroid Implants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Diabetic Retinopathy (Laser Surgeries) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Diabetic Retinopathy (Laser Surgeries) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Diabetic Retinopathy (Vitrectomy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Diabetic Retinopathy (Vitrectomy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Diabetic Retinopathy (Hospitals and Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Diabetic Retinopathy (Eye Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Diabetic Retinopathy (Eye Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Diabetic Retinopathy (Ambulatory Surgical Centres-ASCs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Diabetic Retinopathy (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Diabetic Retinopathy (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia Pacific: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia Pacific: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Diabetic Retinopathy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Diabetic Retinopathy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Global: Diabetic Retinopathy Industry: SWOT Analysis
  • Figure 77: Global: Diabetic Retinopathy Industry: Value Chain Analysis
  • Figure 78: Global: Diabetic Retinopathy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetic Retinopathy Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Diabetic Retinopathy Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Diabetic Retinopathy Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Diabetic Retinopathy Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 5: Global: Diabetic Retinopathy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Diabetic Retinopathy Market: Competitive Structure
  • Table 7: Global: Diabetic Retinopathy Market: Key Players